Literature DB >> 1431014

A review of the psychomotor effects of paroxetine.

I Hindmarch1.   

Abstract

Studies on the behavioural effects of paroxetine on healthy young volunteers, elderly volunteers, and patients suffering from major depressive illness failed to show any evidence of detrimental effects on a battery of objective and subjective measures even when alcohol was taken. In contrast, the chosen verum, amitriptyline or lorazepam, produced significant impairment. The study on depressed patients showed improvement in cognitive functions among the paroxetine group from the start, whereas these functions were, initially, significantly impaired in the dothiepin group. Moreover, the Leeds Sleep Evaluation Questionnaire indicated that dothiepin produced, with respect to paroxetine, a significantly poorer quality of sleep.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1431014     DOI: 10.1097/00004850-199206004-00012

Source DB:  PubMed          Journal:  Int Clin Psychopharmacol        ISSN: 0268-1315            Impact factor:   1.659


  8 in total

Review 1.  Antidepressant use in the elderly. Current status of nefazodone, venlafaxine and moclobemide.

Authors:  R J Goldberg
Journal:  Drugs Aging       Date:  1997-08       Impact factor: 3.923

Review 2.  Paroxetine. An update of its pharmacology and therapeutic use in depression and a review of its use in other disorders.

Authors:  N S Gunasekara; S Noble; P Benfield
Journal:  Drugs       Date:  1998-01       Impact factor: 9.546

Review 3.  Constraints on antidepressant prescribing and principles of cost-effective antidepressant use. Part 2: Cost-effectiveness analyses.

Authors:  J A Henry; C A Rivas
Journal:  Pharmacoeconomics       Date:  1997-06       Impact factor: 4.981

4.  Effective and acceptable treatment for depression.

Authors:  P Madeley; J P Wattis
Journal:  BMJ       Date:  1993-04-24

Review 5.  Behavioural toxicity of medicinal drugs. Practical consequences, incidence, management and avoidance.

Authors:  J G Ramaekers
Journal:  Drug Saf       Date:  1998-03       Impact factor: 5.606

Review 6.  Effects of antidepressants on cognitive functioning of elderly patients. A review.

Authors:  H Knegtering; M Eijck; A Huijsman
Journal:  Drugs Aging       Date:  1994-09       Impact factor: 3.923

7.  Paroxetine : a review of its pharmacology and therapeutic potential in the management of panic disorder.

Authors:  R H Foster; K L Goa
Journal:  CNS Drugs       Date:  1997-08       Impact factor: 5.749

Review 8.  Recent advances in geriatric psychopharmacology.

Authors:  C A Naranjo; N Herrmann; N Mittmann; K E Bremner
Journal:  Drugs Aging       Date:  1995-09       Impact factor: 3.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.